The purpose of this study is to assess the use of the telemedicine platform, Facet, for determining patient satisfaction with inclusion of adjunctive therapy during the care of eczema.
The study is approximately 4 weeks long and is fully remote. During this time, you will use the study product, have weekly follow-up surveys and check-ins with the study team.
You will be compensated up to $150 in the form of an electronic gift card.
Men and Women aged 18 to 64 with mild to moderate eczema and who are currently using the Facet platform
Thirty Madison & Johnson and Johnson (JnJ)
September 30, 2023